Patients with rheumatoid arthritis more likely to quit smoking, shows study

Smoking doubles the risk of developing rheumatoid arthritis and continuing to smoke after being diagnosed has negative effects on patients.

In an Arthritis Care & Research study of patients with rheumatoid arthritis who smoked, certain healthcare factors were linked with a higher likelihood that patients would quit smoking.

In the study that included 507 patients who smoked, 29% quit over a median follow-up of 4.75 years. Compared with other patients, patients new to rheumatology care were 60% more likely to quit smoking and those in the rural community health system were 66% more likely to quit.

Conversely, seropositive patients--who have elevated blood levels of antibodies thought to cause symptoms of their disease--were 43% less likely to quit. Demographic factors were not predictive of smoking cessation.

Our findings point to the impact of health teams that systematically support tobacco cessation, processes that were in place at the rural clinic. Likewise, they highlight the need to engage seropositive patients who smoke and are at risk for worse rheumatoid arthritis and cardiopulmonary diseases, which we know are leading causes of death in rheumatoid arthritis."

Christie M. Bartels, MD, MS, senior author, University of Wisconsin School of Medicine and Public Health

Source:
Journal reference:

Schletzbau, M. et al. (2020) Predictors of Smoking Cessation in Patients with Rheumatoid Arthritis in Two Cohorts: Healthcare Factors Most Predictive. Arthritis Care & Research. doi.org/10.1002/acr.24154.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Weight loss drug semaglutide may offer relief for knee arthritis pain